Formatted single-domain antibodies can protect mice against infection with influenza virus (H5N2)

Antiviral Research

Volumn 97, Issue 3, 2013, Pages 245-254

  Tillib, Sergei V ^a   Ivanova, Tatiana I ^a   Vasilev, Lev A ^a   Rutovskaya, Marina V ^a   Saakyan, Seda A ^a   Gribova, Irina Y ^b   Tutykhina, Irina L ^b   Sedova, Elena S ^b   Lysenko, Andrei A ^b   Shmarov, Maxim M ^b   Logunov, Denis Y ^b   Naroditsky, Boris S ^b   Gintsburg, Alexander L ^b  

^a INSTITUTE OF GENE BIOLOGY   (Russian Federation)

^b GAMALEYA RESEARCH INSTITUTE OF EPIDEMIOLOGY AND MICROBIOLOGY   (Russian Federation)

Author keywords

HMR analysis; Influenza virus; Passive immunization; Recombinant antibody formatting; Single domain antibody

Indexed keywords

NANOBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAMEL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; INFLUENZA A; INFLUENZA A (H5N2); INFLUENZA VIRUS A H5N2; LD 50; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PHAGE DISPLAY; PRIORITY JOURNAL; VIRUS NEUTRALIZATION; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; CAMELS; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNOLOGIC TECHNIQUES; INFLUENZA A VIRUS, H5N2 SUBTYPE; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; SINGLE-DOMAIN ANTIBODIES;

AVIAN INFLUENZA VIRUS; CAMELUS BACTRIANUS; MUS; ORTHOMYXOVIRIDAE;

EID: 84873048474     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2012.12.014     Document Type: Article

References (46)

1. Bumke M.A., Neri D. Affinity measurements by band shift and competition ELISA. Antibody Engineering: Determination of Affinities 2001, 385-396. Springer-Verlag, Berlin, Heidelberg, Germany. R. Kontermann, S. Dubel (Eds.).
2. Conrath K.E., Lauwereys M., Galleni M., Matagne A., Frère J.M., Kinne J., Wyns L., Muyldermans S. Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the S{cyrillic}amelidae. Antimicrob. Agents Chemother. 2001, 45:2807-2812.
3. Conrath K., Lauwereys M., Wyns L., Muyldermans S. Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs. J. Biol. Chem. 2001, 276:7346-7350.
4. Coppieters K., Dreier T., Silence K., de Haard H., Lauwereys M., Casteels P., Beirnaert E., Jonckheere H., Van de Wiele C., Staelens L., Hostens J., Revets H., Remaut E., Elewaut D., Rottiers P. Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis. Arthritis Rheum. 2006, 54:1856-1866.
5. Corti D., Voss J., Gamblin S.J., Codoni G., Macagno A., Jarrossay D., Vachieri S.G., Pinna D., Minola A., Vanzetta F., Silacci C., Fernandez-Rodriguez B.M., Agatic G., Bianchi S., Giacchetto-Sasselli I., Calder L., Sallusto F., Collins P., Haire L.F., Temperton N., Langedijk J.P., Skehel J.J., Lanzavecchia A. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 2011, 333(6044):850-856.
6. De Genst E., Silence K., Decanniere K., Conrath K., Loris R., Kinne J., Muyldermans S., Wyns L. Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. Proc. Natl. Acad. Sci. USA 2006, 103:4586-4591.
7. De Marco D., Clementi N., Mancini N., Solforosi L., Moreno G.J., Sun X., Tumpey T.M., Gubareva L.V., Mishin V., Clementi M., Burioni R. A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses. PLoS ONE 2012, 7(4):e34415.
8. Ekiert D.C., Friesen R.H., Bhabha G., Kwaks T., Jongeneelen M., Yu W., Ophorst C., Cox F., Korse H.J., Brandenburg B., Vogels R., Brakenhoff J.P., Kompier R., Koldijk M.H., Cornelissen L.A., Poon L.L., Peiris M., Koudstaal W., Wilson I.A., Goudsmit J. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 2011, 333:843-850.
9. Friguet B., Chaffotte A.F., Djavadi-Ohaniance L., Goldberg M.E. Mesasurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J. Immunol. Methods 1985, 77:305-319.
10. Ghahroudi M.A., Desmyter A., Wyns L., Hamers R., Muyldermans S. Selection and identification of single-domain antibody fragments from camel heavy-chain antibodies. FEBS Lett. 1997, 414(3):521-526.
11. Ghassabeh G.H., Muyldermans S., Saerens D. Nanobodies, single-domain antigen-binding fragments of camelid heavy-chain antibodies. Current Trends in Monoclonal Antibody Development and Manufacturing 2010, 29-48. Springer, New York. S.J. Shire, W. Gombotz, K. Bechtold-Peters, J. Andya (Eds.).
12. Greenberg A.S., Avila D., Hughes M., McKinney E.C., Flajnik M.F. A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks. Nature 1996, 374:168-173.
13. Hamers-Casterman C., Atarhouch T., Muyldermans S., Robinson G., Hamers C., Songa E.B., Bendahman N., Hamers R. Naturally occurring antibodies devoid of light chains. Nature 1993, 363:446-448.
14. Harbury P.B., Zhang T., Kim P.S., Alber T. A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants. Science 1993, 262(5138):1401-1407.
15. Harmsen M.M., De Haard H.J. Properties, production, and applications of camelid single-domain antibody fragments. Appl. Microbiol. Biotechnol. 2007, 77:13-22.
16. Hmila I., Saerens D., Ben Abderrazek R., Vincke C., Abidi N., Benlasfar Z., Govaert J., El Ayeb M., Bouhaouala-Zahar B., Muyldermans S. A bispecific nanobody to provide full protection against lethal scorpion envenoming. FASEB J. 2010, 24:3479-3489.
17. Hultberg A., Temperton N.J., Rosseels V., Koenders M., Gonzalez-Pajuelo M., Schepens B., Ibañez L.I., Vanlandschoot P., Schillemans J., Saunders M., Weiss R.A., Saelens X., Melero J.A., Verrips C.T., Van Gucht S., de Haard H.J. Lama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules. PLoS ONE 2011, 6(4):e17665.
18. Ibañez L.I., De Filette M., Hultberg A., Verrips T., Temperton N., Weiss R.A., Vandevelde W., Schepens B., Vanlandschoot P., Saelens X. Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection. J. Infect. Dis. 2011, 203(8):1063-1072.
19. Kaminski D.A., Lee F.E. Antibodies against conserved antigens provide opportunities for reform in influenza vaccine design. Front. Immunol. 2011, 2:1-14.
20. Krause J.C., Tsibane T., Tumpey T.M., Huffman C.J., Basler C.F., Crowe J.E. A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin. J. Virol. 2011, 85(20):10905-10908.
21. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227(5259):680-685.
22. Lo C.Y., Wu Z., Misplon J.A., Price G.E., Pappas C., Kong W.P., Tumpey T.M., Epstein S.L. Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: cold-adapted vaccine versus DNA prime-adenovirus boost strategies. Vaccine 2008, 26(17):2062-2072.
23. Muyldermans S., Baral T.N., Retamozzo V.C., et al. Camelid immunoglobulins and nanobody technology. Vet. Immunol. Immunopathol. 2009, 128(1-3):178-183.
24. Nguyen V.K., Desmyter A., Muyldermans S. Functional heavy-chain antibodies in camelidae. Adv. Immunol. 2001, 79:261-296.
25. Nuttall S.D., Krishnan U.V., Hattarki M., De Gori R., Irving R.A., Hudson P.J. Isolation of the new antigen receptor from wobbegong sharks, and use as a scaffold for the display of protein loop libraries. Mol. Immunol. 2001, 38:313-326.
26. O'Shea E.K., Rutkowski R., Kim P.S. Evidence that the leucine zipper is a coiled coil. Science 1989, 243(4890):538-542.
27. Reed L.J., Muench H. A simple method of estimating fifty per cent endpoint. Am. J. Hyg. 1938, 27:493-497.
28. Roovers R.C., Laeremans T., Huang L., De Taeye S., Verkleij A.J., Revets H., de Haard H.J., en Henegouwen P.M.P. Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR nanobodies. Cancer Immunol. Immunother. 2007, 56:303-317.
29. Rothbauer U., Zolghadr K., Tillib S., Nowak D., Schermelleh L., Gahl A., Backmann N., Conrath K., Muyldermans S., Cardoso M.C., Leonhardt H. Targeting and tracing antigens in live cells with fluorescent nanobodies. Nat. Methods 2006, 3:887-889.
30. Saerens D., Kinne J., Bosmans E., Wernery U., Muyldermans S., Conrath K. Single domain antibodies derived from dromedary lymph node and peripheral blood lymphocytes sensing conformational variants of prostate-specific antigen. J. Biol. Chem. 2004, 279:51965-51972.
31. Saerens D., Stijlemans B., Baral T.N., Nguyen Thi G.T., Wernery U., Magez S., De Baetselier P., Muyldermans S., Conrath K. Parallel selection of multiple anti-infectome nanobodies without access to purified antigens. J. Immunol. Methods 2008, 329(1-2):138-150.
32. Shiraishi T., Suzuyama K., Okamoto H., Mineta T., Tabuchi K., Nakayama K., Shimizu Y., Tohma J., Ogihara T., Naba H., Mochizuki H., Nagata S. Increased cytotoxicity of soluble Fas ligand by fusing isoleucine zipper motif. Biochem. Biophys. Res. Commun. 2004, 322(1):197-202.
33. Smirnov Y.A., Lipatov A.S., Van Beek R., Gitelman A.K., Osterhaus A.D., Claas E.C. Characterization of adaptation of an avian influenza A (H5N2) virus to a mammalian host. Acta Virol. 2000, 44:1-8.
34. Sorger P.K., Nelson H.C. Trimerization of a yeast transcriptional activator via a coiled-coil motif. Cell 1989, 59:807-813.
35. Stijlemans B., Conrath K., Cortez-Retamozo V., Van Xong H., Wyns L., Senter P., Revets H., De Baetselier P., Muyldermans S., Magez S. Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm. J. Biol. Chem. 2004, 279:1256-1261.
36. Sui J., Hwang W.C., Perez S., Wei G., Aird D., Chen L.M., Santelli E., Stec B., Cadwell G., Ali M., Wan H., Murakami A., Yammanuru A., Han T., Cox N.J., Bankston L.A., Donis R.O., Liddington R.C., Marasco W.A. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 2009, 16:265-273.
37. Tillib S.V., Ivanova T.I., Vasilev L.A. Fingerprint-like analysis of "nanoantibody" selection by phage display using two helper phage variants. Acta Nat. 2010, 2:85-93.
38. Tillib S.V. "Camel nanoantibody" is an efficient tool for research, diagnostics and therapy. Mol. Biol. (Mosk.) 2011, 45:77-85.
39. Tillib S.V., Ivanova T.I., Lyssuk E.Y., Larin S.S., Kibardin A.V., Korobko E.V., Vikhreva P.N., Gnuchev N.V., Georgiev G.P., Korobko I.V. Nanoantibodies for detection and blocking of bioactivity of human vascular endothelial growth factor A(165). Biochemistry (Moscow) 2012, 77(6):659-665.
40. Vanlandschoot P., Stortelers C., Beirnaert E., Ibañez L.I., Schepens B., Depla E., Saelens X. Nanobodies®: new ammunition to battle viruses. Antiviral Res. 2011, 92:389-407.
41. Vincke C., Loris R., Saerens D., Martinez-Rodriguez S., Muyldermans S., Conrath K. General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold. J. Biol. Chem. 2009, 284:3273-3284.
42. Wesolowski J., Alzogaray V., Reyelt J., Unger M., Juarez K., Urrutia M., Cauerhff A., Danquah W., Rissiek B., Scheuplein F., Schwarz N., Adriouch S., Boyer O., Seman M., Licea A., Serreze D.V., Goldbaum F.A., Haag F., Koch-Nolte F. Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Med. Microbiol. Immunol. 2009, 198:157-174.
43. Whittle J.R., Zhang R., Khurana S., King L.R., Manischewitz J., Golding H., Dormitzer P.R., Haynes B.F., Walter E.B., Moody M.A., Kepler T.B., Liao H.X., Harrison S.C. Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc. Natl. Acad. Sci. USA 2011, 108(34):14216-14221.
44. Wilson I.A., Skehel J.J., Wiley D.C. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 1981, 289(5796):366-373.
45. Yamashita A., Kawashita N., Kubota-Koketsu R., Inoue Y., Watanabe Y., Ibrahim M.S., Ideno S., Yunoki M., Okuno Y., Takagi T., Yasunaga T., Ikuta K. Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: implication for human monoclonal antibody recognition. Biochem. Biophys. Res. Commun. 2010, 393:614-618.
46. Zhang J., Tanha J., Hirama T., Khieu N.H., To R., Tong-Sevinc H., Stone E., Brisson J.R., MacKenzie C.R. Pentamerization of single-domain antibodies from phage libraries: a novel strategy for the rapid generation of high-avidity antibody reagents. J. Mol. Biol. 2004, 335:49-56.